期刊文献+

激素避孕药具的非避孕用途及安全性研究进展 被引量:3

Progress in non-contraceptive effects and safety of hormonal contraceptives
原文传递
导出
摘要 我国目前同时面临着人工流产率不断攀升、辅助生育市场蓬勃发展的奇特现象,表明育龄人群的生育力受到损伤。避孕药具是防止非意愿妊娠、减少人工流产唯一有效的方法,其带来的获益远远大于人工流产带来的风险。一些避孕药还具有非避孕益处以及额外的治疗价值,但同时也伴随着一定的不良反应。深入了解激素类避孕药的药理特性和安全性,为不同年龄和不同需求的人群提供适宜的避孕药具有助于促进避孕药具正确、合理地应用,使之成为保护育龄人群生育功能的重要措施。本文将追踪和介绍近十年来国外新型激素避孕药具产品、非避孕用途和安全性研究进展,为国内避孕药具的研发和应用提供参考。 China is currently facing an abnormal phenomenon in which both artificial abortion rate and assisted reproductive market are rising,suggesting that the fertility of women has been injured.Contraceptives are the only effective way to reduce the artificial abortion from unintended pregnancy,and the benefits they bring far surpass the risks of abortion,and some of contraceptives have extra therapeutic value.However,the efficacy of hormonal contraceptives is also accompanied by unwanted adverse effects as well.Understanding the pharmacological properties and the adverse effects of the contraceptives will conduce to use them properly according to the requirements of all ages,making the contraceptives an important measure to protect the fertility of women.This article will summarize the progress in research and development,non-contraceptive uses and the safety of the contraceptives in the past 10 years,providing new information for the readers.
作者 朱焰 王健 Zhu Yan;Wang Jian(NHC Key Lab of Reproduction Regulation(Shanghai Institute for Biomedical and Pharmaceutical Technologies),Fudan University,Shanghai 200032,China)
出处 《中华生殖与避孕杂志》 CSCD 北大核心 2021年第8期723-730,共8页 Chinese Journal of Reproduction and Contraception
基金 上海市自然科学基金(20ZR1448200) 国家重点研发项目(2016YFC1000904)。
关键词 激素避孕药 非避孕用途 药理特性 不良反应 Hormonal contraceptives Non-contraceptive application Pharmacological profile Adverse effect
  • 相关文献

参考文献6

二级参考文献47

  • 1朱焰,孙祖越,曹霖.醋酸诺美孕酮药理作用研究进展[J].中国药理学通报,2004,20(11):1215-1217. 被引量:1
  • 2杨培娟,林德良,宋思,何美丽,桂幼伦,李腊梅,陈俊康.避孕针剂Mesigyna,Cyclofem对脂、糖代谢及肝功能影响的比较研究[J].生殖与避孕,1994,14(6):427-434. 被引量:2
  • 3朱焰,孙祖越,曹霖.第四代孕激素研究进展[J].中国药学杂志,2006,41(8):572-576. 被引量:16
  • 4居文惠.细胞凋亡与子宫内膜异位症[J].中国优生与遗传杂志,2007,15(6):129-130. 被引量:1
  • 5Khanna J Vanlook PFA 等.生殖健康:走向更美好未来的关键1990-1991.世界卫生组织WHO双年度报告[M].日内瓦,1992.11-12.
  • 6Harel Z, Johnson CC, Gold MA, Cromer B, Peterson E, Burkman R, et al. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections. Contraception 2010; 81 : 281- 291.
  • 7Meier C, Brauchli YB, Jick SS, Kraenzlin ME, Meier CR. Use of depot medroxyprogesterone acetate and fracture risk. J Clin Endocrinol Metab 2010; 95:4909-4916.
  • 8Cromer BA, Scholes D, Berenson A, Cundy T, Clark MK, Kaunitz AM, et al. Depot medroxyprogesterone acetate and bone mineral density in adolescents - the black box warning: a position paper of the society for adolescent medicine. J Adolesc Health 2006; 39: 296-301.
  • 9Dempster DW, Bolognese MA. The evolution of a once-a-month oral therapy for postmenopausal osteporosis. J Clin Densitom 2006; 9: 58-65.
  • 10Nappi C, Bifulco G, Tommaselli GA, Gargano V, Di Carlo C. Hormonal contraception and bone metabolism: a systematic review. Contraception 2012; 86:606-621.

共引文献31

同被引文献21

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部